Cargando…
Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma
Sorafenib is one of the few effective first-line drugs approved for the treatment of advanced hepatocellular carcinoma (HCC). However, the development of drug resistance is common among individuals with HCC. Recent evidence indicated that the anticancer activity of sorafenib mainly relies on the ind...
Autores principales: | Li, Xiaoju, Yu, Qianqian, Zhao, Runze, Guo, Xinyan, Liu, Chenlin, Zhang, Kuo, Zhang, Wangqian, Liu, Jinghan, Yu, Jinzheng, Wang, Shuning, Hao, Qiang, Li, Weina, Zhang, Wei, Li, Meng, Zhang, Yingqi, Zhang, Cun, Gao, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263838/ https://www.ncbi.nlm.nih.gov/pubmed/35814401 http://dx.doi.org/10.3389/fonc.2022.898156 |
Ejemplares similares
-
CD63(+) Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22
por: Gao, Yuan, et al.
Publicado: (2020) -
FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1
por: Liu, Chenlin, et al.
Publicado: (2021) -
Genome-Wide Investigation of Genes Regulated by ERα in Breast Cancer Cells
por: Wang, Shuning, et al.
Publicado: (2018) -
FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
por: Li, Xiaoju, et al.
Publicado: (2018) -
Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer
por: Gao, Yuan, et al.
Publicado: (2018)